Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083

The HIV Prevention Trials Network (HPTN) 083 trial demonstrated that long-acting cabotegravir (CAB-LA) was more effective than tenofovir disoproxil fumarate-emtricitabine (TDF/FTC) in preventing human immunodeficiency virus (HIV) in cisgender men and transgender women who have sex with men. We chara...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	The Journal of infectious diseases Ročník 224; číslo 9; s. 1581
Hlavní autori:	Marzinke, Mark A, Grinsztejn, Beatriz, Fogel, Jessica M, Piwowar-Manning, Estelle, Li, Maoji, Weng, Lei, McCauley, Marybeth, Cummings, Vanessa, Ahmed, Shahnaz, Haines, Casey D, Bushman, Lane R, Petropoulos, Christos, Persaud, Deborah, Adeyeye, Adeola, Kofron, Ryan, Rinehart, Alex, St Clair, Marty, Rooney, James F, Pryluka, Daniel, Coelho, Lara, Gaur, Aditya, Middelkoop, Keren, Phanuphak, Nittaya, Cohen, Myron S, Hendrix, Craig W, Anderson, Peter, Hanscom, Brett, Donnell, Deborah, Landovitz, Raphael J, Eshleman, Susan H
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 16.11.2021
Predmet:	Adolescent Adult Anti-HIV Agents - administration & dosage Diketopiperazines - administration & dosage Female HIV Infections - epidemiology HIV Infections - prevention & control HIV Integrase Inhibitors - administration & dosage Homosexuality, Male Humans Incidence Male Middle Aged Pre-Exposure Prophylaxis Pyridones - administration & dosage Retrospective Studies Transgender Persons Viral Load - drug effects injectable HIV preexposure prophylaxis HPTN 083 TDF/FTC cabotegravir long-acting men who have sex with men prevention
ISSN:	1537-6613, 1537-6613
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!